NCT01436279View on ClinicalTrials.gov

Mifepristone Versus Osmotic Dilator Insertion for Cervical Preparation Prior to Surgical Abortion at 15-18 Weeks

PHASE3CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

August 31, 2013

Study Completion Date

August 31, 2013

Conditions
Cervical Preparation
Interventions
DRUG

Mifepristone

200 mg po 20-24 hours prior to the procedure

DEVICE

osmotic dilators

osmotic dilators placed in the cervix 20-24 hours prior to the procedure

Trial Locations (1)

02130

Boston University, Boston

All Listed Sponsors
collaborator

Society of Family Planning

OTHER

lead

Boston University

OTHER

NCT01436279 - Mifepristone Versus Osmotic Dilator Insertion for Cervical Preparation Prior to Surgical Abortion at 15-18 Weeks | Biotech Hunter | Biotech Hunter